Literature DB >> 22182691

Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Ajay Singh1, Liuting Qing, Qingzhong Kong, Neena Singh.   

Abstract

Prion disease associated neurotoxicity is mainly attributed to PrP-scrapie (PrP(Sc)), the disease associated isoform of a normal protein, the prion protein (PrP(C)). Participation of other proteins and processes is suspected, but their identity and contribution to the pathogenic process is unclear. Emerging evidence implicates imbalance of brain iron homeostasis as a significant cause of prion disease-associated neurotoxicity. The underlying cause of this change, however, remains unclear. We demonstrate that iron is sequestered in heat and SDS-stable protein complexes in sporadic-Creutzfeldt-Jakob-disease (sCJD) brains, creating a phenotype of iron deficiency. The underlying cause is change in the characteristics of ferritin, an iron storage protein that becomes aggregated, detergent-insoluble, and partitions with denatured ferritin using conventional methods of ferritin purification. A similar phenotype of iron deficiency is noted in the lumbar spinal cord (SC) tissue of scrapie infected hamsters, a site unlikely to be affected by massive neuronal death and non-specific iron deposition. As a result, the iron uptake protein transferrin (Tf) is upregulated in scrapie infected SC tissue, and increases with disease progression. A direct correlation between Tf and PrP(Sc) suggests sequestration of iron in dysfunctional ferritin that either co-aggregates with PrP(Sc) or is rendered dysfunctional by PrP(Sc) through an indirect process. Surprisingly, amplification of PrP(Sc)in vitro by the protein-misfolding-cyclic-amplification (PMCA) reaction using normal brain homogenate as substrate does not increase the heat and SDS-stable pool of iron even though both PrP(Sc) and ferritin aggregate by this procedure. These observations highlight important differences between PrP(Sc)-protein complexes generated in vivo during disease progression and in vitro by the PMCA reaction, and the significance of these complexes in PrP(Sc)-associated neurotoxicity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182691      PMCID: PMC3286598          DOI: 10.1016/j.nbd.2011.12.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  56 in total

1.  Formation of native prions from minimal components in vitro.

Authors:  Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 2.  Ferritin and ferritin isoforms I: Structure-function relationships, synthesis, degradation and secretion.

Authors:  A M Koorts; M Viljoen
Journal:  Arch Physiol Biochem       Date:  2007-02       Impact factor: 4.076

3.  Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice.

Authors:  Boe-Hyun Kim; Yong-Chul Jun; Jae-Kwang Jin; Jae-Il Kim; Nam-Ho Kim; Elizabeth A Leibold; James R Connor; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Neurosci Lett       Date:  2007-06-14       Impact factor: 3.046

Review 4.  Role of iron in neurodegenerative disorders.

Authors:  Daniela Berg; Moussa B H Youdim
Journal:  Top Magn Reson Imaging       Date:  2006-02

Review 5.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

6.  Identification of a proteinase K resistant protein for use as an internal positive control marker in PrP Western blotting.

Authors:  G C Saunders; V Horigan; A C Tout; O Windl
Journal:  Res Vet Sci       Date:  2007-03-02       Impact factor: 2.534

Review 7.  Metals ions and neurodegeneration.

Authors:  Francisco Molina-Holgado; Robert C Hider; Alessandra Gaeta; Robert Williams; Paul Francis
Journal:  Biometals       Date:  2007-02-09       Impact factor: 2.949

8.  Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.

Authors:  Christopher J Choi; Vellareddy Anantharam; Nathan J Saetveit; Robert S Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2007-05-04       Impact factor: 4.849

Review 9.  Copper and iron disorders of the brain.

Authors:  Erik Madsen; Jonathan D Gitlin
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

10.  Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.

Authors:  Giovanna R Mallucci; Melanie D White; Michael Farmer; Andrew Dickinson; Husna Khatun; Andrew D Powell; Sebastian Brandner; John G R Jefferys; John Collinge
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

View more
  15 in total

1.  Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice.

Authors:  Pavle Matak; Andrija Matak; Sarah Moustafa; Dipendra K Aryal; Eric J Benner; William Wetsel; Nancy C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  Prion protein promotes kidney iron uptake via its ferrireductase activity.

Authors:  Swati Haldar; Ajai Tripathi; Juan Qian; Amber Beserra; Srinivas Suda; Matthew McElwee; Jerrold Turner; Ulrich Hopfer; Neena Singh
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

3.  Prion protein regulates iron transport by functioning as a ferrireductase.

Authors:  Ajay Singh; Swati Haldar; Katharine Horback; Cynthia Tom; Lan Zhou; Howard Meyerson; Neena Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Authors:  Swati Haldar; 'alim J Beveridge; Joseph Wong; Ajay Singh; Daniela Galimberti; Barbara Borroni; Xiongwei Zhu; Janis Blevins; Justin Greenlee; George Perry; Chinmay K Mukhopadhyay; Christine Schmotzer; Neena Singh
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

Review 5.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

Review 6.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

7.  Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease.

Authors:  Ajai K Tripathi; Neena Singh
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

8.  Upregulation of brain hepcidin in prion diseases.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Dallas McDonald; Alexander E Kritikos; Qingzhong Kong; Neena Singh
Journal:  Prion       Date:  2021-12       Impact factor: 2.547

9.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

Review 10.  Metal and complementary molecular bioimaging in Alzheimer's disease.

Authors:  Nady Braidy; Anne Poljak; Christopher Marjo; Helen Rutlidge; Anne Rich; Tharusha Jayasena; Nibaldo C Inestrosa; Perminder Sachdev
Journal:  Front Aging Neurosci       Date:  2014-07-15       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.